Date: 2015-02-10
Type of information: Collaboration agreement
Compound: Pichia pastoris technology
Company: Boehringer Ingelheim (Germany) VTU Technology (Austria)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On February 10, 2015, Boehringer Ingelheim and VTU Technology, a leading contract research and development company, announced the renewal of their global Pichia pastoris technology collaboration agreement. VTU Technology, currently offering a very broad and versatile technology platform available for Pichia pastoris protein production, will be responsible for carrying out the joint development program in VTU´s facilities in close collaboration between researchers from both companies. Boehringer Ingelheim has decided to prolong their ongoing technology agreement with VTU to further strengthen Pichia´s position as a highly attractive and competitive host for the production of biopharmaceuticals.
Financial terms:
Latest news:
